20 - 22 May, 2019
Sheraton Brussels Airport Hotel, Brussels, Belgium

Main Conference Day 2

8:30 am - 9:00 am Registration and Welcome Coffee

9:00 am - 9:15 am Chairman's Summary of Day One

Steven Jacobs - Board Chairman, Global Clinical Supplies Group

Steven Jacobs

Board Chairman
Global Clinical Supplies Group

9:15 am - 9:50 am Incorporating The Patient Perspective On European Trials - Where, When And How?

Annick Bessems - Director Global Trial Management and GCDO Program Leader- Oncology, Janssen
- Discuss the realities of running oncology trials in Europe: market and patient pressure
- Examine the current patient registration limitations and study protocol limitations for European trials
- Analyse the role of a patient centric approach to trial management as a driver to trial retention and patient engagement

Annick Bessems

Director Global Trial Management and GCDO Program Leader- Oncology

9:50 am - 10:25 am The Case For Orphan Drugs And Their Development In Your Supply Chain

Ana-Zeralda Canals - Clinical Operations Manager, Sanifit
- Review the unique challenges of early access programmes within the clinical supply paradigm
- Examine the benefits of early access programmes for generating real world clinical data to complement your trial data sets
- Discuss the impact of early access program results in generating strong value based pricing and approval applications

Ana-Zeralda Canals

Clinical Operations Manager

10:25 am - 11:00 am Managing An Efficient Clinical Trial Supply Strategy For Rare Disease Clinical Trails

Rawle Dundas - Associate Director, Global Clinical Supply, Alexion Pharmaceuticals
- Discuss the ways that Alexion are approaching the challenge of supplying CTS for rare disease clinical programs
- Analyses how to manage risk of IP stock out with limited drug expiry
- Examine how to create a lean and efficient product supply strategy for multi country trials with a very small patient enrolment

Rawle Dundas

Associate Director, Global Clinical Supply
Alexion Pharmaceuticals

11:00 am - 11:15 am Live Poll!

Use this opportunity to interact with your peers about the key points being discussed so far and share your opinion with
everyone in the room! Live feeding through our app and polls will give you a 360˚ insight on what the industry’s opinion is!

11:15 am - 11:45 am Morning Coffee Break

8:00 am - 8:00 am Stream A: Strategic Stream

11:45 am - 12:50 pm Change Management - How to Minimise It's Effects

Steven Jacobs - Board Chairman, Global Clinical Supplies Group

Steven Jacobs

Board Chairman
Global Clinical Supplies Group

- Examine the importance and benefits of team buy in before implementing organisational change
- Analyse common change management strategies and how they can be adapted to the time sensitive and high pressure nature of the clinical trial supply industry

12:55 pm - 1:30 pm Optimisation Through the Use of a Single Platform for Clinical Trial Anticipatory Management

Irena Seredina - Executive Director, S-Clinica
·         Discuss the application of Clinical Trial platform for the optimisation of study planning, supply forecasting, IRT, cost and risk management
·      Continuously evaluate your supply needs based on real time data and forecasting
·       Keep the costs under control
·       Harmonize forecasting with IRT drug supply management
·       Accurately plan production and distribution whilst ensuring accurate achievements of recruitment targets


Irena Seredina

Executive Director

8:00 am - 8:00 am Stream B: Operational Stream

11:45 am - 12:50 pm Reverse Logistics – Where Product Returns And Destruction Fit Into Your Supply Strategy

Tatjana Vorobjova - Sr Manager, Global Logistics, Investigational Material Supply Chain, Celgene
- Discuss the importance of considering the end to end lifecycle of your clinical supply when looking to implement a lean supply model
- Minimise unforeseen costs by creating a flexible product return and destruction strategy
- Analyse your trial supply reconciliation requirements to ensure end to end alignment in supply management

Tatjana Vorobjova

Sr Manager, Global Logistics, Investigational Material Supply Chain

12:55 pm - 1:30 pm The Geo And Political Effects On Lean And Effective Comparator Sourcing Models

Niklas Mattsson - Global Lead – Comparator Planning, MSD
- Create a global critical trial criteria map to identify sourcing priorities
- Examine the different sourcing models currently being utilised by the CT industry
- Analyse how a mixed-model approach can lead to greater sourcing efficiency than one single model

Niklas Mattsson

Global Lead – Comparator Planning

1:30 pm - 2:30 pm Networking Lunch

- Discuss the importance of ensuring that investment generates equal or greater process efficiency to outweigh cost
- Pin-Point your critical investment opportunities to maximise ROI
- Unpack the importance of securing internal support for investment to maximise implementation success

Kamal Amin

Senior Clinical Supplies Manager
Fujifilm Kyowa Kirin Biologics


Janet Japzon-Salugao

Senior Director, Investigational Medicine Supply Chain


Nancy Meyerson-Hess

Former Head of Clinical Operations and Compliance

3:10 pm - 3:45 pm Dragon's Lair: The Ideal Just In Time (JIT) Labelling Solution

This interactive troubleshooting session targets the key CTS challenge of JIT labelling and packs fun into the bargain too!
Delegates and solution providers will split into teams and conceptualise, research and create a brand new concept for a JIT labelling
solution that would work for big and small companies alike. Once formed each team’s idea will be presented to our judges, who will
vote for the best idea!

3:45 pm - 4:25 pm Scenario Round Tables

Each roundtable will discuss a different “what if” scenario that mirrors a real clinical trial supply time sensitive challenge or
emergency. Develop strategies to overcome these likely scenarios and share past experiences and ideas. You won’t know
the scenario until you choose your roundtable so get ready for some on-the-spot problem solving and out of the box thinking with
your industry peers!

4:25 pm - 4:35 pm Chairman's Summary and End of Main Conference